Secure Asset Management LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 30.9% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 6,098 shares of the healthcare conglomerate's stock after acquiring an additional 1,439 shares during the period. Secure Asset Management LLC's holdings in UnitedHealth Group were worth $3,194,000 at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $26,000. Hurley Capital LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at $28,000. Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $30,000. Finally, Promus Capital LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $32,000. Hedge funds and other institutional investors own 87.86% of the company's stock.
Insider Buying and Selling
In related news, CEO Stephen J. Hemsley bought 86,700 shares of the business's stock in a transaction on Friday, May 16th. The shares were purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer now owns 679,493 shares of the company's stock, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 109,408 shares of company stock worth $31,607,768. Company insiders own 0.33% of the company's stock.
UnitedHealth Group Stock Performance
Shares of UNH traded down $4.77 during mid-day trading on Thursday, reaching $295.61. The company's stock had a trading volume of 12,427,990 shares, compared to its average volume of 6,936,594. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The business has a 50-day simple moving average of $418.00 and a two-hundred day simple moving average of $488.12. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $268.16 billion, a P/E ratio of 19.07, a PEG ratio of 1.37 and a beta of 0.56.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the previous year, the company earned $6.91 earnings per share. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.99%. UnitedHealth Group's payout ratio is currently 35.18%.
Wall Street Analyst Weigh In
Several brokerages have recently weighed in on UNH. JPMorgan Chase & Co. reduced their price objective on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a research report on Thursday, May 15th. Piper Sandler decreased their price objective on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research note on Tuesday. Oppenheimer reduced their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a report on Wednesday, May 14th. Barclays cut their price target on UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a research report on Monday. Finally, Wolfe Research lowered their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $428.43.
Read Our Latest Stock Analysis on UNH
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.